Table 1

Comparison of clinical characteristics of patients with and without Clostridium difficile Infection (CDI)
Characteristic CDI n (%) No CDI n (%) P
No. of Patients 185 7607
Age, y, median (IQR) 69.6 (25.9) 59.1 (30.6) <0.01
CDS-ID Score, median (IQR) 2.83 (1.57) 1.83 (3.21) <0.01
Cancer 12 (6.5) 168 (2.2) <0.01
Diabetes 65 (35.1) 1605 (21.1) <0.01
Kidney Disease 19 (10.3) 289 (3.8) <0.01
Peptic Ulcer Disease 143 (3.2) 4315 (96.8) <0.01
Respiratory Illness 48 (26.0) 1517 (20.0) 0.04
Organ Transplant 14 (7.6) 470 (6.2) 0.44
Any High Risk Antibiotics a 179 (96.8) 6868 (90.3) <0.01

Abbreviations: IQR=Interquartile Range, CDI=Clostridium difficile infection, CDS-ID =Chronic Disease Score-Infectious Disease

a Defined as any cephalosporin, carbapenem, fluoroquinolone, IV vancomycin, or β-lactamase inhibitor combination and derived from observed associations (ref).

Stevens et al.

Stevens et al. BMC Infectious Diseases 2013 13:150   doi:10.1186/1471-2334-13-150

Open Data